Health Trials

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

ConditionTotal Dose of Bupivacaine Administered During Labor
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorMenoufia University

About this trial

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Eligibility criteria

Qualifiers

Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,

normally presented singleton fetus, intact fetal membranes, and who are free of

Disqualifiers

abnormal placental position,

ASA grade>II

marked obesity,

allergy or contraindications to the used drugs,

Trial design

Treatments tested in this trial

  • Epidural Catheter with bupivacaine
  • Epidural with dural puncture
  • Dexmedetomidine 0.4 added
  • Dexmedetomidine 0.6 added

Treatment groups

140 Participants
are divided into 4 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Faculty of Medicine Menoufia University Status unavailable 32511, Shebeen El KomEgyptEgypt

Sponsors and collaborators

Menoufia University

Lead sponsor

Source ClinicalTrials.gov